1. Schreuders, EH, Ruco, A, Rabeneck, L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015; 64: 1637–1649.
Google Scholar | Crossref | Medline | ISI2. Chiu, H-M, Chen, SL-S, Yen, AM-F, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the one million Taiwanese screening program. Cancer 2015; 121: 3221–3229.
Google Scholar | Crossref | Medline | ISI3. Moss, S, Mathews, C, Day, TJ, et al. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Gut 2017; 66: 1631–1644.
Google Scholar | Crossref | Medline4. Shapiro, JA, Bobo, JK, Church, TR, et al. A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. Am J Gastroenterol 2017; 112: 1728–1735.
Google Scholar | Crossref | Medline5. Tinmouth, J, Lansdorp-Vogelaar, I, Allison, JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 2015; 64: 1327–1337.
Google Scholar | Crossref | Medline | ISI6. Meklin, J, SyrjÄnen, K, Eskelinen, M. Fecal occult blood tests in colorectal cancer screening: systematic review and meta-analysis of traditional and new-generation fecal immunochemical tests. Anticancer Res 2020; 40: 3591–3604.
Google Scholar | Crossref | Medline7. Cooper, JA, Parsons, N, Stinton, C, et al. Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model. Br J Cancer 2018; 118: 285–293.
Google Scholar | Crossref | Medline8. Cooper, JA, Moss, SM, Smith, S, et al. FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical test. Colorectal Dis 2016; 18: 650–653.
Google Scholar | Crossref | Medline9. StataCorp . Hurdle models, www.stata.com/features/overview/hurdle-models/ (2020, accessed 30 July 2020).
Google Scholar10. StataCorp . Stata 16 base reference manual: Cragg hurdle regression. College Station, TX: Stata Press, 2019.
Google Scholar11. Fraser, CG, Benton, SC. Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations. Clin Chem Lab Med 2019; 57: 611–616.
Google Scholar | Crossref | Medline12. Steele, RJ, McDonald, PJ, Digby, J, et al. Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United Eur Gastroenterol J 2013; 1: 198–205.
Google Scholar | SAGE Journals | ISI13. Clark, G, Strachan, JA, Carey, FA, et al. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme. Gut 2021; 70: 106–113.
Google Scholar | Crossref | Medline14. Bretagne, JF, Piette, C, Cosson, M, et al. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening. Dig Liver Dis 2019; 51: 1461–1469.
Google Scholar | Crossref | Medline15. Guo, F, De Brabander, I, Francart, J, et al. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme. Br J Cancer 2020; 122: 1109–1117.
Google Scholar | Crossref | Medline16. Sultanian, R, Du, L, Moysey, B, et al. The impact of transitioning from guaiac-fecal occult blood testing to fecal immunochemical testing in a Canadian colon cancer screening program. J Can Assoc Gastroenterol 2020; 3: 177–184.
Google Scholar | Crossref | Medline17. Clark, GRC, Strachan, JA, McPherson, A, et al. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies. Clin Chem Lab Med 2020; 58: 2073–2080.
Google Scholar | Crossref | Medline18. Quyn, AJ, Fraser, CG, Stanners, G, et al. Uptake trends in the Scottish bowel screening programme and the influences of age, sex, and deprivation. J Med Screen 2018; 25: 24–31.
Google Scholar | SAGE Journals | ISI19. Catomeris, P, Baxter, NN, Boss, S, et al. Effect of temperature and time on fecal hemoglobin stability in 5 fecal immunochemical test methods and one guaiac method. Arch Pathol Lab Med 2018; 142: 75–82.
Google Scholar | Crossref | Medline20. Symonds, EL, Cole, SR, Bastin, D, et al. Effect of sample storage temperature and buffer formulation on faecal immunochemical test haemoglobin measurements. J Med Screen 2017; 24: 176–181.
Google Scholar | SAGE Journals | ISI21. Hansen, AT, Hoffmann-Lucke, E, Nielsen, BK, et al. Delayed sample arrival at the laboratory does not lead to more false negatives in the Danish population screening for colorectal cancer. Scand J Clin Lab Invest 2017; 77: 685–688.
Google Scholar | Crossref | Medline